Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma - Test2 - elhamkhani - TriplyDB

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q24627680

about

The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review EMT-Inducing Molecular Factors in Gynecological Cancers Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)Circulating RNAs as new biomarkers for detecting pancreatic cancer Burden of gastrointestinal cancer in Asia; an overview Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1 Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.Molecular signatures of pancreatic cancer.miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT.Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines.Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas Regulation of cancer metastasis by cell-free miRNAs.Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.Advances in biomarker research for pancreatic cancer.Cell-free Circulating miRNA Biomarkers in Cancer Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.MicroRNAs as Biomarkers in Cancer.miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.Targeting microRNAs in pancreatic cancer: microplayers in the big game.Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.MicroRNAs in pancreatic malignancy: progress and promises.Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.MicroRNAs in pancreatic cancer metabolism.Biomarkers for early diagnosis of pancreatic cancer.

P2860

Q26744831-FF1F8477-86D1-4C15-882B-C77E564CA81D Q26748510-1D2D2149-F57A-464B-9E70-30D7DFA30121 Q26749037-EA0A6E01-720A-46CE-A62B-7BA87BD6488E Q26765233-AF3848E9-6CD6-4D68-9263-F44EA99147BD Q26769953-854A126D-026F-4225-B05A-5F6C69B44C37 Q26774628-F20D0389-37FF-4F04-8BFA-BA15CB1FA7EE Q26781912-DB633AA1-0CA7-4B6C-B4B2-7F2D3F4884CE Q26796523-89083309-A5C7-421B-B2CD-1DF4F9315F46 Q26801191-72B0905C-254F-4483-8D9B-FD856E0F4785 Q26865299-2EA1ABFA-5ECB-4F31-B6C4-3BCF9AF1C647 Q26991615-C6452759-D1F9-48F9-9D45-EE6AAAA6FC19 Q28079735-39857872-D369-4C66-A50E-1935A39C29CE Q30541314-14D74762-0C26-4BC2-A838-D381642A6E7C Q33561359-1BD2DDE1-1079-4511-AE2A-BB0F067031C0 Q33586516-D3131F8A-DBB0-4B4C-818E-5EEA7F76299B Q33889404-7632A91A-9CF1-42A0-8B53-52A301C0E311 Q33918801-434A041D-D510-48EF-A797-EACC387A4C1C Q34069609-5F2693FD-6F0E-479E-9B5E-DA05B5312EF7 Q34127316-88DC9CCA-4F35-4A4A-B732-21912D2A123B Q34533633-1CA8F0E2-544E-43F3-A006-E15476C8AA71 Q34775829-C15A6A9D-ACB6-410F-A742-D9774F303BDF Q34994302-06772C57-76EA-40FA-BC8B-E9C06A5108FD Q35034340-FFFED1DE-4BF1-4EE2-9AA2-CA8141C80E92 Q35038199-69BAAF88-AD2B-4753-BDFA-D90A47F648DD Q35123631-21FC64CE-A88F-4F9A-8801-6FB8E12E9AC4 Q35588532-145D0952-CBD4-4754-A729-592B35A9B2ED Q35820915-FC8A0EB7-A81A-48DC-A4C5-4BD529029587 Q36126609-0645D2E3-D0AE-40B2-86E1-967A0989314A Q36316601-47A6F221-CCD3-45F0-9939-B8D7153F3993 Q36319389-5B680CAE-ECAD-464C-BDB4-457B5E0CB759 Q36335261-BD153975-F0B4-4339-91F5-A7E439972180 Q36541286-B9450395-4DEC-453A-9815-D6F4A2E1178D Q37075919-2E838F09-74F3-4A00-89D1-BCAF26A6416E Q37325758-029160E9-8523-4C51-A395-71671FAA12EF Q37520294-AE0BB79B-997A-497A-939E-61AAC83A306B Q37694882-E0320F37-5EE0-4946-9F36-45B78A1F2D55 Q37707057-F5CE46EC-4333-4C53-B339-EDC7DFFE74D7 Q37822465-7B782188-D890-4F64-9550-E820C78B92A7 Q38003048-69637912-F9F0-4F50-AAAF-C8D31833ED55 Q38265405-FEC236D6-8F70-423C-82E2-6DF5E2E659D7

P2860

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q24627680

description

2010 nî lūn-bûn

@nan

2010 թուականին հրատարակուած գիտական յօդուած

@hyw

2010 թվականին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@ast

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@en

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@nl

type

label

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@ast

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@en

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@nl

prefLabel

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@ast

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@en

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@nl

P1433

Q24627680-F29D3157-5227-40BF-B524-F2D98C27E675

P1476

Q24627680-74C47BEF-5C33-4365-9D19-C175E66B68E8

P2093

Q24627680-8F2EC5E0-0F72-41EF-8741-02FA3692F1A2

Q24627680-CD869899-880E-4EEA-AB9E-CF6D6160525C

Q24627680-FA4D49ED-A5A8-4888-9B46-292C3CD46E2A

P2860

Q24627680-0605E7D9-C7DE-4BCF-A8A2-6E2D0ABA3C5F

Q24627680-1D43AB7E-7AB2-4FF7-8778-762596793440

Q24627680-2082CD2F-5D00-4910-AE01-8417CAF296BF

Q24627680-21D866EF-AEFA-42C1-B3DC-BA4C27AB937B

Q24627680-22A20532-79A7-4F22-8B50-AB17B7E53B95

Q24627680-23892A40-469C-4BFD-85A1-7C75475F2BA2

Q24627680-256BE009-10A4-4E54-A082-EBEC6B4D9EB3

Q24627680-2B85CA33-2F97-44ED-8E55-39C989E2372B

Q24627680-303CF94F-1015-45DA-AD97-4DD80B4F66CB

Q24627680-37802F2A-EC1B-44CF-88A3-C66A955D99D6

P304

Q24627680-4E8A7A57-CCE2-4F63-AA0E-694750C6E817

P31

Q24627680-D9C0072B-FDDC-4378-85D7-A6B1840FEE2C

P3181

Q24627680-062F2681-4761-4E71-B4DC-88BABE66B979

P356

Q24627680-72C738CC-F6C3-4B37-91A9-00B153F2F10B

P407

Q24627680-C4B04334-688A-46E2-A525-DDF7676EDEE6

P433

Q24627680-1E1CEC53-9906-49D4-B06F-27A94AB65A44

P478

Q24627680-ADB3457B-C349-40B0-873F-8B722E3DA2BF

P50

Q24627680-0D9D7FE6-6734-4664-A2CF-D892AE47B7A9

Q24627680-872DEDB1-7381-4EA7-9767-BA69D3A281D0

Q24627680-ED791007-74E3-4D27-86D5-2588E9204A02

P577

Q24627680-3E51A617-E82B-4E8C-BF9D-EC60A37B1A7F

P5875

Q24627680-D357C6CE-E2A6-43CE-AA2E-52A17C22E969

P698

Q24627680-71FC01A5-840B-47DA-BC7B-4015C5DCC718

P921

Q24627680-6F9F1913-E100-4006-9156-5F06DDD62EEF

Q24627680-73F4E36B-F50F-42FE-A5A4-A3A6E3804BE0

P932

Q24627680-4D714691-881F-4F66-B08E-6AC3EBB6EDFD

P3181

P356

P1433

P1476

Aberrant MicroRNA-155 expressi ...... n of pancreatic adenocarcinoma

@en

P2093

Collins A Karikari

http://www.w3.org/2001/XMLSchema#string

Ji Kon Ryu

http://www.w3.org/2001/XMLSchema#string

Michael G Goggins

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

A microRNA expression signature of human solid tumors defines cancer gene targets

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

Widespread microRNA repression by Myc contributes to tumorigenesis

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

P304

66-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1272768

http://www.w3.org/2001/XMLSchema#string

P356

10.1159/000231984

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42441057

http://www.w3.org/2001/XMLSchema#string

P698

20332664

http://www.w3.org/2001/XMLSchema#string

P921

P932

2865485

http://www.w3.org/2001/XMLSchema#string